TMPRSS2 and COVID-19: Moreover, TMPRSS2 is involved in the cleavage of the spike protein of SARS-CoV-2, and a TMPRSS2 inhibitor has been described that can block cell entry of the virus [148], representing a possible therapeutic strategy for the treatment of COVID-19 (Figure 6).